Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

GSK778 hydrochloride

SKU: orb1297936

Description

GSK778 hydrochloride is a potent and selective BD1 bromodomain inhibitor of BET proteins, demonstrating low nanomolar IC50 values. It mimics pan-BET inhibitor effects in cancer models, making it a valuable tool for epigenetic research in oncology, applicable in both cellular and in vivo studies of transcriptional regulation and tumor progression.

Research Area

Cell Biology, Epigenetics & Chromatin

Images & Validation

Key Properties

CAS Number2863657-79-6
MW548.08
Purity98.35% (May vary between batches)
FormulaC30H34ClN5O3
SMILESC[C@@H](N1C(COC)=NC2=C1C3=CC(OC[C@@H]4CNCC4)=C(C5=C(C)ON=C5C)C=C3N=C2)C6=CC=CC=C6.[H]Cl
TargetApoptosis,Epigenetic Reader Domain
SolubilityDMSO:50 mg/mL (91.23 mM)

Bioactivity

Target IC50
BRD3 BD1:41 nM|BRDT BD1:143 nM|BRD2 BD1:75 nM|BRD4 BD1:41 nM
In Vivo
GSK778 hydrochloride (15 mg/kg/BID; i.p. for 30 days) offers a superior survival advantage to iBET-BD2 in the aggressive MLL-AF9 AML model. GSK778 hydrochloride (15 mg/kg/BID; s.c. for 14 days) reduces the production of anti-keyhole limpet hemocyanin (KLH) IgM and is well tolerated. GSK778 hydrochloride exhibits Cmax (85 ng/mL), Tmax (1.48 h) and AUC∞ (132 ng.h/mL) following oral administration (10 mg/kg) in mice.
In Vitro
GSK778 hydrochloride inhibits BRD BD2 with the IC50s of 3950 nM (BRD2 BD2), 1210 nM (BRD3 BD2), 5843 nM (BRD4 BD2), and 17451 nM (BRDT BD2), respectively. GSK778 hydrochloride (0.01-10 μM; 72 hours) inhibits the proliferative activity of human primary CD4+ T cells and the production of effector cytokines including IFNγ, IL-17A and IL-22. GSK778 hydrochloride (0.001-10 μM; 5 days) has a more pronounced effect on the growth and viability of MDA-453, MOLM-13, K562, MV4-11, THP-1, and MDA-MB-231 cells. GSK778 hydrochloride (1000 nM; 72 hours) inhibits proliferation, induces a cell cycle arrest and apoptosis in MV4-11, MOLM13, MDA-MB-231 and MB453 cells. GSK778 hydrochloride (1000 nM; 12 days) reduces the clonogenic capacity of primary human AML cells.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

BET, EpigeneticReaderDomain, Epigenetic Reader Domain, GSK-778 Hydrochloride, GSK778 Hydrochloride, GSK778 hydrochloride, GSK 778 Hydrochloride
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 160.00
5 mg
$ 310.00
1 ml x 10 mM (in DMSO)
$ 380.00
10 mg
$ 430.00
25 mg
$ 640.00
50 mg
$ 870.00
100 mg
$ 1,150.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry